Clinical Focus ›› 2015, Vol. 30 ›› Issue (5): 512-516517.

Previous Articles     Next Articles

A meta-analysis on the effects of regimen SOX versus FOLFOXs in treatment of advanced gastric cancer

Li Xu;Li Hongen;Li Jingya   

  • Online:2015-05-05 Published:2015-05-05

Abstract: Objective S-1 is a novel oral derivative of 5-FU combined with oxaliplatin and widely used to treat the advanced gastric cancer.In this study,the clinical effects and adverse reactions will be compared between the regimens SOX and FOLFOXs for chemotherapy

Key words: stomach neoplasms, antineoplastic combined chemotherapy protocols, TS-1, meta-analysis

CLC Number: